Pharmacodynamic noninferiority study comparing subcutaneous injections of efgartigimod PH20 with intravenous infusions of efgartigimod: results of phase 3 ADAPTsc study-MedSci.cn

Pharmacodynamic noninferiority study comparing subcutaneous injections of efgartigimod PH20 with intravenous infusions of efgartigimod: results of phase 3 ADAPTsc study

Casey, J; Howard, J; Li, G; Vu, T; Bril, V; Margania, T; Korobko, D; Smilowski, M; Banaszkiewicz, K; Liu, L; Steeland, S; Noukens, J; Van Hoorick, B; Podhorna, J; Li, Y; Utsugisawa, K; Wiendl, H; De Bleecker, J; Mantegazza, R

NEUROMUSCULAR DISORDERS, 2022; 32 ():

科室
- - 订阅+
  - 更多科室
工具
服务